| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/25/2009 | CN101584690A 2, 3, 3a, 4-tetrahydrothiochromeno2H-pyrazole serial compound with anticancer activity |
| 11/25/2009 | CN101584689A Compound eardrops containing antipyrine and lidocaine the and preparation method thereof |
| 11/25/2009 | CN101584688A Medicament composition for treating diabetes and complications of diabetes |
| 11/25/2009 | CN101584687A Application of alfa-ketoglutaric acid iron in preparing iron-filling drug and health care product |
| 11/25/2009 | CN101584686A Application of sodium valproate during preparing medicament for treating retina disease |
| 11/25/2009 | CN101584685A Medicine composition for regulating blood fat |
| 11/25/2009 | CN101584684A Enteric preparation containing stable salts of S-adenosyl-L-methionine and preparation method thereof |
| 11/25/2009 | CN101584683A Metolazone slow-release capsule and method for preparing same |
| 11/25/2009 | CN101584682A Rutin-arabic-gum-gelatin slowreleasing microspheres and preparation thereof |
| 11/25/2009 | CN101584680A Tablet capsule containing clopidogrel hydrogen sulfate salt tablets and acetylsalicylic acid tablets |
| 11/25/2009 | CN101584678A Sertaconazole antibacterial effervescing agent, preparation method and application thereof |
| 11/25/2009 | CN101584677A Trimebutine maleate sustained-release tablet |
| 11/25/2009 | CN101584676A Matrine sustained release preparation and preparing method thereof |
| 11/25/2009 | CN101584675A Slow-release avermectin tablet for livestock and poultry and preparing method thereof |
| 11/25/2009 | CN101584674A Venlafaxine hydrochloride sustained-release tablet preparation and preparation method thereof |
| 11/25/2009 | CN101584673A Levetiracetam tablet and preparation method |
| 11/25/2009 | CN101584672A Clofarabine pharmaceutical composition freeze-dried powder injection and preparation method thereof |
| 11/25/2009 | CN101584671A Cefazedone sodium medicament powder injection and method for synthesizing raw medicine of Cefazedone sodium |
| 11/25/2009 | CN101584670A Decitabine freeze-dried powder injection |
| 11/25/2009 | CN101584669A Melphalan freeze-dried powder injection |
| 11/25/2009 | CN101584668A Bendamustine hydrochloride freeze-dried powder injection |
| 11/25/2009 | CN101584667A Biodegradation type long-acting contraception microsphere and preparation method and application thereof |
| 11/25/2009 | CN101584666A Preparing method of proton pump inhibitor biological adhesive preparation |
| 11/25/2009 | CN101584665A Cefotiam hydrochloride medicament composition sterile powder injection and preparation method thereof |
| 11/25/2009 | CN101584664A Cefodizime sodium proliposome preparation and preparation method thereof |
| 11/25/2009 | CN101584663A Novel delivery system of Duoxitasai lipidosome for injection and preparation method thereof |
| 11/25/2009 | CN101584662A Etoposide lipidosome and preparation method thereof |
| 11/25/2009 | CN101584661A Preparation of sorafenib self-microemulsifying drug delivery system for oral administration or intravenous injection and use thereof |
| 11/25/2009 | CN101584660A Intravenous injection perilla alcohol submicron emulsion and preparation method thereof |
| 11/25/2009 | CN101584659A Docetaxel medicament composition injection and preparation method thereof |
| 11/25/2009 | CN101584658A Preparation method of amikacin sulfate injection |
| 11/25/2009 | CN101584657A Tilmicosin solution and preparation method thereof |
| 11/25/2009 | CN101584656A Novel use of amikacin sulfate injection |
| 11/25/2009 | CN101584655A High-purity salidroside injection preparation and preparation method thereof |
| 11/25/2009 | CN101584654A Ofloxacin nasal drops as well as preparation method and quality control method thereof |
| 11/25/2009 | CN101584653A Stable suppository containing roxithromycin |
| 11/25/2009 | CN101584652A Risperidone sustained-release gel injection and preparation method thereof |
| 11/25/2009 | CN100562748C Method of predicting spot formation on the skin with the use of spot site-accelerating genes as indication and method of screening inhibitor for spot formation on the skin |
| 11/25/2009 | CN100562521C Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon |
| 11/25/2009 | CN100562520C Imidazole derivatives iii |
| 11/25/2009 | CN100562518C Novel arylethene-sulfonamides compounds |
| 11/25/2009 | CN100562514C Substituted propion amide derivatives, their preparing method and use |
| 11/25/2009 | CN100562513C Benzamide derivative or salt thereof |
| 11/25/2009 | CN100562342C Oligonucleotide drug for preventing and treating influenza virus infection |
| 11/25/2009 | CN100562333C Chinese traditional medicine for creating coronary heart disease and heart angina and the preparation method |
| 11/25/2009 | CN100562322C Colon target prepn. contg. 5-aminosalicylic acid, and its preparation method |
| 11/25/2009 | CN100562321C Application of diosgenin in preparing medicine with synergistic attenuation |
| 11/25/2009 | CN100562320C Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1 lambda 6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-n-methyl-isobutyramide |
| 11/25/2009 | CN100562319C 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 11/25/2009 | CN100562318C Process for producing crystal |
| 11/25/2009 | CN100562317C Granules containing acid-unstable chemical in large amount |
| 11/25/2009 | CN100562316C Cis-imidazolines as MDM2 inhibitors |
| 11/25/2009 | CN100562315C Active compound of Baojiwan pill for resisting diarrhea and reducing gastrointestinal illness |
| 11/25/2009 | CN100562314C Use of phthalide derivatives for the treatment and prevention of diabetes mellitus |
| 11/25/2009 | CN100562313C Combined use of a fibrate and orlistat for the treatment of obesity |
| 11/25/2009 | CN100562312C Novel use of peptide compounds for treating dyskinesia |
| 11/25/2009 | CN100562311C Cisplatin preparation method and its application method |
| 11/25/2009 | CN100562309C Injectable composition of clopidogrel and its salt and preparation method thereof |
| 11/25/2009 | CN100562273C Medicinal ear pillow |
| 11/25/2009 | CN100562257C Use of resveratrol for food |
| 11/24/2009 | US7622612 Tricyclic derivatives and their use |
| 11/24/2009 | US7622611 N-(5-methanesulfonyl-2-methyl-4-pentafluorosulfanylbenzoyl)guanidine; antiarrhythmic medicaments with cardioprotective component for prophylaxis and treatment of infarction and angina pectoris; also inhibit preventively pathophysiological processes associated with development of ischemia-induced damage |
| 11/24/2009 | US7622610 Topical, oily skin disorders such as acne; N-benzyl-N'-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide |
| 11/24/2009 | US7622595 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid |
| 11/24/2009 | US7622594 Indazole-based compounds having trifluoromethyl and hydroxy-alkyl substitution at position 5; e.g. 2,2,2-Trifluoro-1-(1-phenyl-1H-indazol-5-yl)-1-quinolin-4-ylethanol; inflammatory, allergic, or proliferative diseases |
| 11/24/2009 | US7622593 Human protein tyrosine phosphatase inhibitors and methods of use |
| 11/24/2009 | US7622592 N-(3,5-dichlorobenzyl)-N'-[2-(1,3-thiazol-4-yl)-1H-benzimidazol-5-yl]urea; androgen receptor (AR) modulators (agonists) in tissue-directed therapy (bone, muscle) while antagonizing the AR in the prostate or uterus; bone disorders; peridontal disease; sarcopenia; atherosclerosis; antiarthritic agents; |
| 11/24/2009 | US7622589 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists |
| 11/24/2009 | US7622583 4-((5-Chloro-3-(4-methyl-3-trifluoromethylbenzenesulfonylamino)pyridin-2-yl)-oxo-)1H-pyrrolo(2,3-)pyridine;interfere with ligand (monocyte chemoatactic protein-1) for chemokine receptors (CCR2); antiinflammatory agents; immunomodulators; bactericides; viricides; fungicides |
| 11/24/2009 | US7622582 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one |
| 11/24/2009 | US7622579 Hetero isonipecotic modulators of vanilloid VR1 receptor |
| 11/24/2009 | US7622576 Halide-free glucosamine base and method of preparation |
| 11/24/2009 | US7622575 For connective tissue injuries; bone and skin disorders; water insoluble |
| 11/24/2009 | US7622574 Antisense poly-2'-O-(2,4-dinitrophenyl protected)oligoribonucleotides; monoclonal antibodies, antigen binding fragments; lymphocyte growth inhibitors |
| 11/24/2009 | US7622572 AXMI-028 and AXMI-029, a family of novel delta-endotoxin genes and methods for their use |
| 11/24/2009 | US7622563 Reacting alkyl gallate with glucose pentaacetate in presence of organic solvent and acid catalyst (boron trifluoride) while removing organic solvent and acetic acid formed; distillation |
| 11/24/2009 | US7622556 Modified cytokines for use in cancer therapy |
| 11/24/2009 | US7622530 Biocompatible block copolymer comprising one or more elastomeric blocks and one or more thermoplastic blocks connected by a seed polymer |
| 11/24/2009 | US7622508 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 11/24/2009 | US7622507 Substituted organosulfur compounds and methods of using thereof |
| 11/24/2009 | US7622506 Treating diabetic foot ulcer by topically administering a compound selected from (R)-1-(5,8-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-4-methylpent-3-enyl acetate and 5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)naphthalene-1,4-dione |
| 11/24/2009 | US7622505 Association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it |
| 11/24/2009 | US7622504 E.g., 3-acetoxy-2-(2-chloro-5-(difluoromethoxy)phenyl)propanenitrile; useful at very low concentrations; treatment of ring worm and athlete's foot, as well as fungal infection of the toenails |
| 11/24/2009 | US7622503 Selective androgen receptor modulators and methods of use thereof |
| 11/24/2009 | US7622502 Rheumatic diseases, influenza, common cold, pain, dysmenorrhea, headache, toothache, sprains and strains, neuralgia, synovitis,arthritis, osteoarthritis, gout, bursitis, burns, injuries, and inflammation; cardiovascular disorders, anticoagulants; side effect reduction |
| 11/24/2009 | US7622501 Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors |
| 11/24/2009 | US7622500 Antiparasitic agents |
| 11/24/2009 | US7622499 (2S,3S)-3-Benzyloxy-N-[7-(carboxymethoxy) coumarin-4-ylmethoxy]carbonylaspartate; upon photoirradiation can produce compounds exhibiting a function of suppressing the glutamate uptake activity of L-glutamate transporters; use in treatment of neurological disorders and neurodegenerative conditions |
| 11/24/2009 | US7622498 applying insecticides with high toxicity against adult fruit flies but very low toxicity to brine shrimps; less toxic for ecosystem, environmentally friendly |
| 11/24/2009 | US7622497 Such as -(Morpholin-4-yl)-ethyl gambogate; 2-Dimethylaminoethyl gambogate; N-[3-(4-Methyl-piperazin-1-yl)-propyl]gambogamide;N-(3-Morpholin-4-yl-propyl)gambogamide; Methyl 37,38-Dihydroxy-gambogate; Methyl 37,38-Dihydroxy-9,10-dihydro-10-morpholinyl-gambogate; anticarcinogenic agent |
| 11/24/2009 | US7622495 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents |
| 11/24/2009 | US7622494 Chemical compounds |
| 11/24/2009 | US7622493 Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof |
| 11/24/2009 | US7622492 antidiabetic agents; (4S,7R)-1-Benzyl-7,8,8-trimethyl-2-phenyl-1,2,4,5,6,7-hexahydro-4,7-methano-indazol-3-one; treating metabolic disorder comprises diabetes, obesity or metabolic syndrome, type II diabetes |
| 11/24/2009 | US7622491 Modulators of PPAR and methods of their preparation |
| 11/24/2009 | US7622490 Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| 11/24/2009 | US7622489 Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl)-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-dihydro-1N-pyrrol-1-carboxamide |
| 11/24/2009 | US7622488 Use of a pyrazole derivative for preparing medicines useful for treating renal diseases |
| 11/24/2009 | US7622487 Piperidine derivative, process for producing the same, and use |
| 11/24/2009 | US7622486 Pyridine compounds, process for their preparation and compositions containing them |